Supreme Court Decision on Mifepristone
On May 4, 2026, the U.S. Supreme Court temporarily restored nationwide access to the abortion pill mifepristone, blocking a lower court ruling that had reinstated an in-person dispensing requirement.
1)
On May 4, 2026, the U.S. Supreme Court temporarily restored nationwide access to the abortion pill mifepristone, blocking a lower court ruling that had reinstated an in-person dispensing requirement.
1)
Justice Samuel Alito issued an administrative stay that allows the drug to continue being prescribed via telehealth, dispensed at pharmacies, and delivered by mail, maintaining the status quo as of May 1.
2)
2)
The stay, effective through at least May 11, 2026, pauses a decision by the conservative 5th U.S. Circuit Court of Appeals, which had sided with Louisiana in its lawsuit against the FDA.
3)
3)
The 5th Circuit had ruled that mifepristone must be obtained in person, reversing pandemic-era rules finalized by the Biden administration in 2023.
Drug manufacturers Danco Laboratories and GenBioPro filed emergency appeals,
4)
Drug manufacturers Danco Laboratories and GenBioPro filed emergency appeals,
4)
warning of “chaos” and “immediate confusion” for patients and providers.
The Supreme Court has requested responses from Louisiana and the FDA by May 7, after which the full court will decide how to proceed.
5)
The Supreme Court has requested responses from Louisiana and the FDA by May 7, after which the full court will decide how to proceed.
5)
This is not a final ruling. The case centers on whether Louisiana has legal standing to challenge federal regulations, similar to a 2024 Supreme Court decision that dismissed a prior challenge on standing grounds.
6)
6)
Court issues temporary order allowing access to abortion pill by mail
7)scotusblog.com/2026/05/aborti…
7)scotusblog.com/2026/05/aborti…
@threadreaderapp unroll
• • •
Missing some Tweet in this thread? You can try to
force a refresh
